WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CARIS wurde als Wortmarke am 11.01.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1675798 |
| Länder | 
|
| Basismarke |
Nr. ,
02. Oktober 2024
|
| Anmeldedatum | 11. Januar 2022 |
| Ablaufdatum | 11. Januar 2032 |
Markeninhaber
750 West John Carpenter Freeway, Ste 800
Irving TX 75039
US
Irving TX 75039
US
Markenvertreter
One West Fourth Street
Winston-Salem NC 27101
US
Waren und Dienstleistungen
42
Medical research; medical and scientific research services
in the fields of anatomic pathology, molecular profiling,
blood-based diagnostics, oncology, genomics, and proteomics;
pharmaceutical research and development; genetic and
proteomic research studies of specimens; genetic and
proteomic research studies of specimens, namely, cellular
manipulation, light microscopic examination,
immunohistochemistry flow cytometry, expression profiling,
microarray analysis, genetic signatures, specific genetic
targets, DNA/RNA isolation and western blot analysis,
facilitating effective clinical trials, product development,
and research using large amounts of biospecimens and
associated research and patient data; providing temporary
use of nondownloadable software for tracking laboratory
information featuring customized biospecimens and
coordinating and conducting follow-on studies to complement
the clinical findings; medical and scientific research;
providing medical and scientific research in the fields of
oncology, and molecular profiling, genomics and proteomics;
conducting clinical trials; medical research laboratory
services, namely, analysis of individualized patient data to
aid physicians in determining diagnostic, therapeutic and
prognostic objectives for patients; medical research
laboratory services, namely, providing patient history
reports based on analysis of RNA, DNA and protein to aid
physicians in determining diagnosis, prognosis, and
predicting or monitoring therapeutic response for cancer
patients; providing a centralized database in the field of
molecular diagnostics to allow oncologists to acquire and
share molecular tumor profiling information and clinical
outcomes within a collaborative, secured environment, all
for treatment and diagnostic purposes
44
Medical diagnostic, theranostic, prognostic and analysis
services, namely, pathology diagnostic services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. August 2023 | 2023/31 Gaz | PH | Ablehnung |
| 22. Juni 2023 | 2023/26 Gaz | JP | Ablehnung |
| 08. Juni 2023 | 2023/26 Gaz | US | Korrektur |
| 11. Januar 2023 | 2023/18 Gaz | US | Korrektur |
| 09. November 2022 | 2022/46 Gaz | US | Korrektur |
| 11. Januar 2022 | 2022/29 Gaz | US | Eintragung |
ID: 141675798